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Abstract
Background: Amniotic epithelial cells (AEC) have potential applications in cell-based therapy. Thus far their ability to
differentiate into tenocytes has not been investigated although a cell source providing a large supply of tenocytes remains
a priority target of regenerative medicine in order to respond to the poor self-repair capability of adult tendons. Starting
from this premise, the present research has been designed firstly to verify whether the co-culture with adult primary
tenocytes could be exploited in order to induce tenogenic differentiation in AEC, as previously demonstrated in
mesenchymal stem cells. Since the co-culture systems inducing cell differentiation takes advantage of specific soluble
paracrine factors released by tenocytes, the research has been then addressed to study whether the co-culture could be
improved by making use of the different cell populations present within tendon explants or of the high regenerative
properties of fetal derived cell/tissue.
Methodology/Principal Findings: Freshly isolated AEC, obtained from ovine fetuses at mid-gestation, were co-incubated
with explanted tendons or primary tenocytes obtained from fetal or adult calcaneal tendons. The morphological and
functional analysis indicated that AEC possessed tenogenic differentiation potential. However, only AEC exposed to fetal-
derived cell/tissues developed in vitro tendon-like three dimensional structures with an expression profile of matrix (COL1
and THSB4) and mesenchymal/tendon related genes (TNM, OCN and SCXB) similar to that recorded in native ovine tendons.
The tendon-like structures displayed high levels of organization as documented by the cell morphology, the newly
deposited matrix enriched in COL1 and widespread expression of gap junction proteins (Connexin 32 and 43).
Conclusions/Significance: The co-culture system improves its efficiency in promoting AEC differentiation by exploiting the
inductive tenogenic soluble factors released by fetal tendon cells or explants. The co-cultural system can be proposed as a
low cost and easy technique to engineer tendon for biological study and cell therapy approach.
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Introduction
Tendon overuse injuries, which are referred to as tendinopathy
affect millions of people in occupational and sport settings [1,2].
Until the present time, pharmacological (anti-inflammatory) and
non-pharmacological therapies (physiotherapy and surgical inter-
vention) provide exclusively symptomatic relief [3–5] since an
effective treatment able to stimulate a complete process of tendon
healing remains to be developed. Biologically based strategies able
to stimulate cells activity and extracellular matrix deposition have
received increasing attention [3]. In this context, stem cell-based
therapy seems to represent the most promising frontier to restore
tendon function [3,6–8]. Spontaneous healing is generally
incomplete and frequently leads into fibrosis, thus, compromising
the biomechanical properties of tendon causing significant
dysfunction and disability. Although the mechanism involved in
this failure remains still unknown, it probably resides in the high
degree of differentiation of this tissue and in the low cellularity that
limits the capacity of differentiated tenocytes to replicate in adult
organisms [3,9]. For this reason, cell-based therapy or tissue
engineering were suggested as an ideal approach to support
tendon healing [3,10], and to this aim several cell types have been
used under preclinical settings [8].
Autologous tenocytes seem to be the more appropriate cells for
their innate ability to develop the highly organized tendon
extracellular matrix in the absence of any risk of immune-
rejection. However, the few tenocytes harvested from adult tissue
and the high morbidity of the donor site have severely limited the
use of autologous cells [3].
Stem/progenitor cells have been alternatively proposed for a
direct transplantation or after a previous in vitro differentiation into
tenocyte-like lineage [8]. Mesenchymal stem cells (MSCs) have
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ability to integrate within tendon host tissue, a transgenic
transformation was adopted [8]. Until now, different transgenic
approaches have been proposed either to up regulate growth
factors involved in tendon repair [13,14], or gene expression
controlling tenocyte-lineage differentiation [15,16].
An efficient tenogenic differentiation protocol has recently been
proposed for MSCs based on their co-culture with primary
tenocytes [17–19]. The co-incubation with differentiated cell lines
as osteoblast [20], chondrocytes [21], and tendon-ligament cells
[17–19] seems, in fact, to commit stem/progenitor cells versus the
relative cell lineage phenotype. The co-culture systems involved
the direct cell-cell interaction [19] or the use of cell-specific
conditioned medium [17,18]. This last approach appears to be
particular attractive since it operates under the stimulatory
influences of paracrine humoral factors released by appropriate
cell types, thus, allowing a low cost process of in vitro differentiation
eliminating any undesirable risk of cell contamination. The co-
culture systems, in addition, reproducing the specific microenvi-
ronment that physiologically regulate cell development, tissue
maintenance, and regeneration may represent also a valid tool to
test in vitro the ability of stem/progenitor cells to undergo tissue
specific differentiation before attempting the site-directed delivery
into healthy or injured tissues.
Starting from these premises, the present research was designed
to verify whether the co-culture could be applied to epithelial
derived amniotic cells (AEC), and whether the efficiency of the co-
cultural system could be improved by using fetal samples, with
higher regenerative properties, or tissue explants co-cultures.
To these aims, AEC immediately after isolation were co-
cultured in the presence of adult vs. fetal tendon explants or,
alternatively, with the respective primary derived cells (fetal or
adult tenocytes). The tenogenic inductive potential of different co-
cultures were compared under the 28 days of incubation (7, 14, 28
days) by analyzing cell phenotype, cell proliferation index and by
monitoring the in vitro molecular AEC reprogram versus tendon
lineage tissue.
The present results indicate that all tendon derived samples
(tissue explants and tenocytes) are able to generate a favorable
microenvironment for tenogenic differentiation. Co-cultured
AEC, in fact, stepwise differentiated to tenogenic lineage evolving
through a mesenchymal transition phase. Interestingly, tenocytes
and explants derived from the fetus possessed the highest
tenogenic differentiative properties that led AEC to form in vitro
tendon-like structures with a more mature morphological
organization and molecular profile. Altogether, these data suggest
that AEC combined with co-culture may provide a low cost and
large supply of tenocytes and/or engineered tendons to develop
novel cell-based therapy.
Results
AEC characterization
The enzymatic digestion of amniotic membranes allowed to
isolate a purified AEC population as documented by the
cytokeratin 8 expression and the molecular profile indicated by
the flow cytometry (Fig. 1). In detail, freshly isolated AEC did not
display any haemopoietic markers (CD14, CD58, CD31 e CD45).
On the contrary, the cells expressed several surface adhesion
molecules (CD29, CD49f and CD166), and the stemness markers
TERT, SOX2, OCT4 and NANOG, while the CD117 resulted
not expressed.
RT-PCR indicated that AEC clearly expressed Collagen type 3
(COL3) and Trombospondin 4 (THBS4), lower levels of Collagen
type 1 (COL1), and Tenomodulin (TNMD), while did not express
Scleraxis B (SCXB) and Osteocalcin (OCN).
Freshly isolated ovine AEC showed the ability to differentiate
into cells from all three germ layers (Fig. 1). Endodermal lineage
differentiation was obtained by incubating AEC under hepatic
conditions. Round cells expressing the hepatic marker albumin
were recorded after 10 days of culture. Analogously, the cells
cultured in an osteoinductive medium showed an intense
extracellular matrix mineralization described by Alizarin red
staining.
Finally, AEC expressed the nestin marker when incubated in
the presence of a neurogenic agent, the trans-retinoic acid. The
differentiation towards neural cells was also suggested by the
typical elongated cell morphology assumed by ,15% of nestin
positive cells.
AEC morphology and activity were influenced by
co-culture systems
The AEC cultured in a-MEM containing 10% FCS and
without any growth factors (Table 1) proliferated with a medium
doubling time of ,38 hours during the first week of incubation
reaching confluence in ,3 weeks.
The proliferation index analyzed from the second week of
incubation progressively dropped passing from ,40% to ,5% at
day 28 (Table 1).
AEC maintained a typical polyhedral shape and did not display
any tendency to form three dimensional (3-D) aggregates once
confluence was reached (Fig. 2). The expression of cytokeratin 8
persisted, while alpha smooth muscle actin (a-SMA), on the
contrary, showed very low levels of expression (Fig. 3).
By contrast, AEC co-cultured with tendon explants or tenocytes
assumed different levels of cell organization (Fig. 2).
In detail, during the first 2 weeks of incubation all co-cultured
AEC formed a coherent cellular sheet attached on the bottom of
the well (Fig. 2). The cell sheets developed quickly several 3-D
circular aggregates that appeared at the end of the first week of
incubation in AEC co-cultured with fetal tendon explants and later
under the other co-cultural conditions. The 3-D circular
aggregates grew and progressively elongated, thus detaching from
the monolayer substratum but maintaining some peripheral
contacts with the well walls. The morphological evolution of the
3-D circular aggregates occurred earlier (14
th day) in AEC co-
cultured with fetal tenocytes or explants, while, it required 3–4
weeks in AEC exposed to adult derived cells/tissues. Then, the 3-
D elongated structures developed more organized tendon–like
structures displaying fusiform aligned cells with flat nuclei (Fig. 2,
3). In particular, in AEC co-cultured with fetal explants or fetal
tenocytes, a mean of two-three tendon-like structures were
observed within each well with a size ranging from 0.4 mm to
2 mm in length. The majority of co-cultured AEC migrated within
the 3-D structures and only a very low percentage remained plated
on the well bottom (,10%). The tenocytes cultured within the
trans-well compartment did not generate organized 3-D tendon-
like structures. AEC maintained under different co-culture systems
displayed a doubling time ranging from a maximum of 33 hours
(adult explants) to a minimum of 23 hours (fetal explants) during
the first week of incubation, as summarized in Table 1. The
proliferation index recorded in AEC co-cultured during the
second week of incubation with fetal explants or fetal tenocytes
was slightly higher than that recorded in AEC alone (,40 and
30%, respectively: p.0.05 vs. AEC; Table 1), but significantly
higher than that of AEC co-cultured with adult derived tendon or
tenocytes (,19 and 12%, respectively; p,0.05 vs. both fetal co-
cultures). The differences amongst the proliferation index persisted
Tenogenic Differentiation of AEC
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cultured with fetal tendon explants (,40%), while a lower
proliferation index was observed in AEC co-cultured with adult
explants (,25%) and fetal tenocytes (,30%). The lowest
proliferation index was observed in AEC exposed to adult
tenocytes (,8%).
Co-culture induced AEC epithelial-mesenchymal
transition
AEC maintained in culture their polyhedral shape, a high
incidence of cytokeratin 8 positivity, and did not express a-SMA.
The AEC did not display any migratory activity during the first
week of incubation (Fig. 3A).
By contrast, the expression of cytokeratin 8 progressively
dropped in AEC incubated in co-culture, in parallel with the
organization of 3-D cell aggregates. In fact, the AEC that
remained plated on the well bottom conserved a high level of
cytokeratin 8 positivity, did not express a-SMA, showing the
conservation of the original epithelial phenotype (Fig. 3B arrows).
By contrast, all the cells that formed the 3-D aggregates down
regulated cytokeratin 8 and switched-on a-SMA. This aspect
became particular evident in the tendon-like structures, as shown
in Fig. 3B. The above epithelial-mesenchymal transition was first
observed in AEC exposed to fetal tendon explants (day 7), the only
cells that acquired the ability to migrate (Fig. 3A).
The MHC class I and II antigens, telomere length and
karyotype were not affected by the cultural and co-cultural
conditions. In detail, telomere length was not affected by 28 days
of incubation independently from the cultural conditions adopted
(Fig. 3C). More in detail, freshly isolated AEC displayed an area
(TEA) of 0.1460.09, a feret maximum (TEF) of 0.4960.18, and a
mean densitometric value (MEAND) of ,66.48624.51 that
remained stable (TEA 0.1360.07; TEF max 0.4860.16; MEAND
66.43623.84: p.0.05 for all the parameters) after 28 days of
incubation. Similarly, TEA ranged between a minimum of
0.1160.06 and a maximum of 0.1260.09 in AEC co-cultured
with fetal and adult tendon explants, respectively; the TEF
maximum ranging between a minimum of 0.4760.14 and
0.4860.12 in AEC co-cultured with fetal tendon explants and
adult tenocytes, respectively; MEAND ranged between a mini-
Figure 1. Molecular characterization of freshly isolated AEC. A) Levels of surface and intracellular stemness markers analyzed by flow
cytometry and expressed as Mean Fluorescence Intensity (MFI) ratio. B) The mRNA content of tendon-related genes analyzed by RT-PCR. The bars
show the standard error calculated on 3 independent experiments. C) Two representative images of cytokeratin 8 (epithelial marker) and a-SMA
(mesenchymal marker) proteins detected in AEC by using an immunocytochemistry approach. The images show the blue nuclei counterstained with
DAPI, and both proteins in red (Cy3). Scale bar for all images=50 mm. D) The in vitro differentiation of AEC into endoderm (liver: bottom image) and
ectoderm (neural cells: top image) cell lineages are documented by the immunocytochemistry detection of nestin and albumin, respectively. Nuclei
were counterstained with DAPI. The mesodermal osteogenic in vitro differentiation (central image) was documented by the Alizarin Red staining.
Scale bar for all images=50 mm.
doi:10.1371/journal.pone.0030974.g001
Tenogenic Differentiation of AEC
PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e30974mum of 64.89621.89 and a maximum of 65.28620.56 in AEC
co-cultured with fetal and adult tenocytes, respectively. The
telomere parameters recorded in the different groups of co-
cultured AEC were similar to those recorded in freshly isolated
AEC (p.0.05 for all parameters) and cultured AEC (p.0.05), but
significantly greater than those recorded in fetal tenocytes (TEA
0.0860.05, TEF max 0.4060.13, MEAND 44.01613.24; p,0.05
for all parameters; Fig. 3C).
The structures and the modal number of chromosomes
analyzed in undifferentiated (time 0 and 28 days; Fig. 3) and
differentiated AEC indicated a constant chromosomal number
(n=54; Fig. 3D) and confirmed the absence of gross chromosomal
instability during the incubation.
All the tested AEC, independently from the cultural conditions
adopted, maintained a similar and stable expression profiles for
MHC class I and II antigens. In particular, freshly isolated
(Fig. 3E), cultured and co-cultured AEC displayed a low
expression of MHC class I molecule (MFI ratio ranging between
2.5 and 4), and the absence of MHC class II (HLA-DR) antigens
(MFI ratio always .1).
Fetal explants and tenocytes triggered AEC tenogenic
differentiation
Immunohistochemistry revealed that all the co-cultured AEC
progressively increased their intracytoplasmic content of COL1
protein.
Large amounts of COL1 appeared in AEC forming the 3-D
aggregates (Fig. 4). On the contrary, the protein was not detectable
for 28 days either in AEC cultured alone or in AEC forming the
monolayer (Fig. 4).
In detail, the highest levels of COL1 were recorded within the
more organized tendon-like structures developed in vitro by AEC
exposed to fetal tendon explants or fetal tenocytes. In these
structures the protein was first observed within the fusiform cells
Figure 2. Morphology of differentiated AEC toward tenocyte lineage after co-culture. The four top images reproduce the more
representative phenotypes acquired by AEC (monolayer, circular aggregates, elongated, and tendon-like structures) during the 4 weeks of co-
incubation. The bigger images were obtained with the aid of a contrast microscope, while the small ones, inserted in the corner, represent a low
magnification recorded under a stereomicroscope. In the lower part of the Table, the incubation intervals (expressed in weeks) required to obtain
these different phenotypes are indicated. Scale bar for all images=50 mm.
doi:10.1371/journal.pone.0030974.g002
Table 1. Proliferation activity recorded in AEC maintained in
culture for 28 days alone or in co-incubation with tenocytes
and tendon explants derived from fetal or adult calcaneal
tendons.
Co-cultural systems Doubling time (hours) Proliferation index (%)
Day 7 Day 14 Day 28
AEC 3864.2 3864.4 660.9
AEC plus fetal:
Tenocytes 2661.6* 3263.8 2963.2
a
Explants 2360.9* 4064.6 3864.3
b
AEC plus adult:
Tenocytes 2964.8 1262.1
b 861.5
Explants 3363.4 1962.3
b 2363.2
a
The doubling time was expressed as media 6 SD of 3 replicates obtained from
at least 3 different experiments. The data were compared by One Way ANOVA
test followed by post-hoc Tukey test.
*Asterisk indicates values significantly different within the column (p,0.05).
The proliferation indexes are expressed as the % of Ki-67 positive cells/total
cells recorded in 3 replicates obtained from at least 3 different experiments/
group. The data were compared by One Way ANOVA test followed by post-hoc
Tukey test.
a,bDifferent superscripts indicate values significantly different within each
column (p,0.05).
doi:10.1371/journal.pone.0030974.t001
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extracellular spaces (late phase; Fig. 4). The tendon-like
structures were the only 3-D structures that expressed OCN,
connexin (Cx) 32 and 43 (Fig. 5). In fact, while COL1 positive
cells were present in all the 3-D structure (Fig. 4), OCN and Cx
proteins were observed only in tendon-like structures (Fig. 5).
The OCN was clearly localized into the cytoplasm of the
fusiform shaped cells forming the 3-D tendon-like structures
where no ALP positivity was observed, thus confirming the
absence of any osteogenic in vitro differentiation (inset in Fig. 5).
Moreover, the in vitro differentiated AEC forming 3-D tendon-
like structures co-expressed Cx 32 and 43. During the early
phase of 3-D structure formation several cells displayed Cx 43
punctuate foci on the membranes. Later, the tendon-like
structures showed high levels of both proteins that connected
the fusiform cells to each other, thus forming a syncytial
functional network. The fusiform cells produced large amounts
of Cx 43 that resulted localized either on the membrane or into
the cytoplasm, suggesting a protein transfer from the cytoplasm
to the membrane (Fig. 5).
Figure 3. Molecular, genomic, and functional characterization of co-cultured AEC. A) The top images are two representative examples of
migration testes perfomed in cultured and co-cultured AEC during the first week of incubation. As indicated by the+symbol, only the AEC co-cultured
with fetal tendon explants show a migration activity. B) Representative images of immunocytochemistry showing the distribution of cytokeratin 8
and a-SMA in AEC co-cultured with fetal primary tenocytes after 14 or 28 days of incubation. All images show cell nuclei in blue (DAPI) and both the
proteins in red (Cy3). At day 14, the co-cultured AEC organized in monolayer display high levels of cytokeratin 8, and undetectable levels of a-SMA. A
similar molecular phenotype is displayed by monolayered AEC cultured alone (small insets) or co-cultured with fetal tenocytes (arrows in large
figures) for 28 days. By contrast, an opposite behaviour is observed in co-cultured AEC that organized cell-aggregates. Scale bar for all
images=100 mm. C) Q-FISH detection of telomere length in freshly isolated AEC (AEC), in cultured AEC (AEC 28 days), in AEC co-cultured with fetal
explants (AEC+fetal explants 28 days), and fetal tenocytes. The top figure is a representative image showing several hybridized red telomeres (Cy3)
within two interphase nuclei stained in blue with DAPI. Scale bar=15 mm. The three box plots indicate the Telomere area (TEA), the feret maximum
(TEF), and the mean densitometric value (MEAND) parameters. The horizontal lines express the 5th, 25th, 50th, 75th, and 95th percentile of the
distribution. The box stretches from the 25th to the 75th percentile, and therefore contains the middle half of the scores in the distribution. The
median is shown as a line across the box, meanwhile the mean value as a black square within the box.
* indicates data of TEA, TEFmax, and MEAND
that resulted significantly different from AEC for p,0.01 after One Way ANOVA test followed by post-hoc Tukey test. D) Three representative normal
karyotypes obtained by freshly isolated AEC (day 0), cultured AEC and cells co-cultured in the presence of fetal explants. E) Flow cytometry for the
major histocompatibily (MHC) class I and II molecules performed on ovine peripheral blood mononuclear cells (PBMC; top image) to test the ovine
reactivity of both the antibodies and on freshly isolated AEC (bottom images) to demonstrate the presence of the MHC class I and the absence of
MHC class II antigens.
doi:10.1371/journal.pone.0030974.g003
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ligament related genes
As summarized in Fig. 6, gene expression profiles performed
after 28 days of incubation confirmed that fetal co-cultures (tendon
explants or tenocytes) were more effective in promoting tenogenic
in vitro differentiation.
SCXB and TNMD, two specific tendon/ligament related
genes, highly expressed in native ovine adult or fetal tendons,
were significantly up regulated in AEC co-cultured with fetal
explants or fetal tenocytes (p,0.05 vs. AEC alone). By contrast,
SCXB mRNA content was low in AEC co-cultured with the
adult tissue or primary adult tenocytes (p.0.05 for both vs.
AEC) where, in parallel, TNMD mRNA levels significantly
decreased (p,0.05 vs. AEC). Analogously, OCN was switched-on
exclusively in AEC exposed to fetal tissues/cells even if their
mRNA content was lower than that recorded in fetal and adult
tendons (p,0.05 for both vs. fetal tendon). In parallel, AEC
incubated under fetal co-cultures up regulated COL1 that
reached significantly higher values than those recorded in
cultured AEC (p,0.05 for both) and observed in native tissues
(p,0.05; Fig. 6). By contrast, fetal co-cultures did not affect
COL3 and THBS4 mRNA content.
Adult co-cultures stimulated different expression profiles (Fig. 6).
In detail, the COL3 and THBS4 mRNA contents remained stable
Figure 4. COL1 distribution in AEC aggregates developed in co-culture. The images exemplify the COL1 protein distribution recorded by
immunohistochemistry in the more representative typologies of cell aggregates obtained during AEC co-cultures. The images show in blue the nuclei
counterstained with DAPI and in green the COL1 protein (Alexa Fluor 488). The COL1 protein is undetectable when the AEC are organized in
monolayer independently from the cultural conditions adopted (co-cultured AEC, monolayer; AEC cultured alone, small inset). COL1 starts to appear
in AEC forming cell aggregates and reaches its highest and widespread distribution within the tendon-like structures. In the early phase, COL1 is
localized within the fusiform cells that start to be oriented along the longitudinal axis of the tendon-like structures. Later, the protein was either
localized into the AEC or deposited within the extracellular matrix (tendon-like: late phase). Scale bar for all images=100 mm.
doi:10.1371/journal.pone.0030974.g004
Figure 5. OCN, Cx32 and Cx43 proteins distribution in AEC co-cultured with fetal tenocytes or tendon explants. Representative
images showing osteocalcin (OCN: lower panel) and connexins (Cx32 or Cx43: upper panel) immunolocalization in AEC cultured alone (AEC) and in
AEC co-cultured fetal derived cell/tissues that developed 3D structures. The pictures show the cell nuclei in blue (DAPI), OCN or Cx32 proteins in
green (Alexa Fluor 488) and Cx43 in red (Cy3). The co-expression of Cx proteins on AEC cell aggregates were analyzed with a double immunostaining.
OCN and both the Cx proteins were undetectable in AEC cultured alone (AEC) and in AEC organized within elongated aggregates. By contrast, AEC
that differentiated 3-D tendon-like structures co-expressed Cx32 and Cx43. The Cx43 protein shows higher levels in the early tendon-like structures
with a clear membrane localization, while Cx32, more abundant in late structures, is localized either on the membrane or into the cytoplasm. OCN
appears as a cytoplasmatic protein within the fusiform shaped cells forming the tendon-like structures (early phase). Its intracellular levels
progressively increased during the process of in vitro tendon differentiation (late phase). As indicated in the corner box showing a representative
image of an ALP assay, tendon-like structures did not display any osteogenic foci. Scale bar for all images=50 mm.
doi:10.1371/journal.pone.0030974.g005
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cells co-cultured with adult tenocytes. By contrast, adult tenocytes
or explants significantly increased the mRNA levels of COL1 and
decreased TNMD mRNA content, respectively. Moreover, both
the adult co-cultures were unable to up regulate the expression of
OCN and SCXB.
Figure 6. Expression profile of tendon/ligament-related genes in co-cultured AEC. The mRNA content of SCXB, COL1, COL3, TNMD, THSB4,
OCN was analyzed in cultured AEC or in AEC co-cultured with fetal or adult tenocytes/tendons explants by using RT-PCR. The semi quantitative
analyses of mRNA levels were normalized for GAPDH gene and expressed as mean of 3 different replicates 6 SD. The data were compared by One
Way ANOVA test followed by post-hoc Tukey test.
* Values significantly different from AEC group for p,0.05;
a values significantly different from fetal
tendon group for p,0.05;
a9 values significantly different from adult tendon group for p,0.05.
doi:10.1371/journal.pone.0030974.g006
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The present work demonstrates, for the first time, that ovine
AEC can be differentiated into tenocytes by using an appropriate
co-cultural microenvironment. The AEC may, thus, represent a
promising source of tenocyte/tenocyte progenitor cells which
together with MSCs and embryonic stem cells (ESC) can be used
to develop cells for transplantation or for the production of
engineered tendons [8]. This aspect may have crucial clinical
relevance because the extremely low availability of autologous
tenocytes or progenitor cells has so far strongly limited the
development of a cell-based therapy for tendinopathy [3,4].
Amniotic membranes, that in human could be collected by the
term placenta as a discarded tissue with few ethical issues [22–24],
may provide a large amount of AEC. Amniotic derived cells for
veterinary medicine could be advantageously obtained directly
from the placenta of slaughtered pregnant animals.
More in detail, the present paper showed that ovine AEC can
stepwise differentiate in vitro into tenocytes through an epithelial-
mesenchymal transition stage. The process is more consistent in
co-culture with fetal derived cells/tendon explants that provides a
powerful and low cost strategy for improving tenogenic in vitro
differentiation.
Taking into account that the regenerative properties of a tissue
is strictly age-related [25–28], we have compared the inductive
properties of fetal vs. adult tendon samples in co-culture. Several
authors demonstrated, in fact, that the complex interaction
between extrinsic and cell-intrinsic influences limit tissue regener-
ation during the transition from fetus to adult life. Extrinsic factors,
such as changes in the precursor cell niche, local or systemic
signals, exert a primary role in concert with cell intrinsic pathways
[29,30]. These aspects are particularly relevant when adult and
fetal tissue regenerative properties are compared. In contrast to
adult tissue repair, extensive experimental evidences showed that
fetal tissues in early and mid-gestational stage, like that used in the
present work, respond to injuries in a highly efficient manner. In
general, fetal wound healing occurs at a faster rate and without
any scar formation in different animal models [31,32]. Recent
investigations demonstrated that these high regenerative properties
are intrinsic to fetal tendon itself [33,34]. Cells isolated from fetal
ligament exhibit enhanced cellular migration and collagen
production [28] in comparison to cells from adult tissue. In
addition, sheep fetal tendon transplanted into an adult environ-
ment responds to injuries in an intrinsic manner of the tissue itself
by displaying a rapid morphological regeneration, and by
recovering normal mechanical properties [33]. Although the
mechanisms involved are still unknown, these data strongly
indicate that the intrinsic regenerative capability of the fetal
tendon may be dependent on specific intracellular pathways and/
or the local secretion of peculiar paracrine factors that could
explain the maintenance of the regenerative properties of the
transplanted fetal tendon, and the fibrotic evolution in an adult
injured tendon. The co-culture systems used did not require any
cell-cell interaction, but simply operated under the stimulatory
influences of paracrine humoral factors released by the different
inductive samples. Under these co-culture systems we were able to
discriminate between the tenogenic inductive properties exerted
by fetal vs. adult and cells vs. tissue explants.
Fetal samples were able to direct AEC into a fully differentiated
tenogenic phenotype.
Firstly, fetal co-cultures increased the AEC proliferative activity
and induced a prompt epithelial-mesenchymal transition as
documented by cytokeratin 8 and a-SMA expression, and by
the acquisition of a clear migration ability. Epithelial-mesenchy-
mal transition occurred during the first two weeks of incubation
and was accelerated by fetal tendon explants. The higher
stimulatory inductive properties of fetal samples (explants and
tenocytes) were then confirmed by the analysis of cell morphology,
of the 3-D aggregate structures, and by SCXB, matrix (TNMD,
COL1 and 3, THBS4), and mesenchymal (OCN) gene expression.
The combination of the above parameters was adopted as the only
way to interpreter the degree of in vitro tenogenic differentiation in
the absence of any specific tendon tissue markers [8], and of
ultrastructural analysis showing the collagen fibrils in tendon-like
structures [35]. The study of gene expression, however, well
describes the tenogenic evolution of the co-cultured AEC showing
that only after co-culture with fetal samples, AEC assumed an
expression profile similar to that of native ovine adult and fetal
tendons.
Amongst the considered different genes, the expression of SCXB
promoted by fetal samples appeared the more remarkable event,
considering that SCXB is the best characterized tendon neo-
formation molecular marker [36,37]. SCXB, in fact, is a member
of the basis-helix-loop-helix (bHLH) super-family of transcription
factors involved in developmental processes such as tendon
formation and tendon muscle attachment during fetal life [38].
Additional evidences suggested a positive role of SCXB also in
adult tendon homeostasis as co-activator of other tendon
correlated genes as COL1 [39] and TNMD [40]. Analogously,
the induction of SCXB gene expression in AEC exposed to fetal
paracrine factors was, in parallel, accompanied by the switching
on of TNMD, and OCN as well as by the up regulation of COL1.
Similarly, the global gene profile expression clearly showed the
different tenogenic potential of adult and tendon explants and
adult primary tenocytes. Adult primary tenocytes, that represent
the more used source of cells for the co-cultural systems [18,19],
showed, actually, the lowest tenogenic differentiative influence on
ovine AEC. Adult tenocytes, in fact, displayed a lower ability than
fetal tenocytes to stimulate AEC proliferation, and to induce
mesenchymal transition. In addition, in the presence of adult
tenocytes AEC down-regulated the expression of matrix-related
genes as COL3, TNMD, and switched off the THSB4.
Co-cultured ovine AEC were able to form coherent cellular
sheets and yield tendon-like structures in the absence of a 3-D
culture system [19], scaffold support [41,42], and any mechanical
stimuli [8]. The tendon-like structures reached high levels of
organization in terms of morphological and molecular phenotypes,
in particular, in the presence of fetal cells/tissues co-cultures. In
fact, the in vitro tendons obtained with fetal soluble factors
contained layered fusiform cells that expressed high intracellular
levels of COL1 and OCN proteins. OCN is considered
predominantly a marker associated to osteogenesis, but other
reports indicated that this protein is expressed in tendon and
tendon cell lineages [15]. In the present work, OCN was chosen to
confirm the new protein profile induced in AEC by co-culture
since anti-sheep SCXB and TNMD antibodies specific for
immunohistochemestry are not commercially available. In order
to exclude a possible correlation between OCN and osteogenic
foci in the in vitro produced tendon, however, the ALP negativity
was, in parallel, documented.
The tendon-like structures developed in co-cultures with fetal
derived cells/tendon explants, in addition, were the only 3-D
structures displaying COL1 proteins deposited in the extracellular
matrix.
The higher level of organization of these tendon-like structures
was, finally, suggested by the expression of both Cx proteins
forming the gap junction communication system typical of fetal
and adult tendons [43]. The gap junctions that link tenocytes
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mechanical coordination and strain-induced collagen synthesis
[44–47]. A 3-D network of gap junctions appeared in the tendon-
like structures after 3–4 weeks of co-incubation with fetal derivates,
enabling them to respond potentially better to mechanical stimuli
that could be exploited to further improve their organization [8].
In conclusion, a highly efficient co-culture system capable to
program AEC through tenogenic soluble factors has been
identified.
The co-cultural system with fetal cell/tendon derivates guaran-
teed the formation of tendon-like structures for biological study
and cell-therapy application when applied to AEC or other MSCs.
The co-culture system, in addition, appears able to conserve the
AEC characteristics since it did not affect telomere length,
karyotype, and the expression of histocompatibility antigens of
class I and II.
In particular, the HLA expression of ovine AEC reproduced
what it has been demonstrated in human AEC, thus suggesting
that these cells may be applicable in clinical transplantation
settings under auto/allo/xenogeneic conditions [48–52]. The
autologous use of amniotic-derived cells has been proposed for
the uterus cell transplantation aimed to treat congenital disorders
[53], or for cell-based therapies in adult life after AEC bio-banking
[22–24]. The allo/xenogeneic use has been also hypothesized as a
consequence of the AEC immunomodulatory [52,54–56], and low
tumorigenic properties [22–24]. However, independently of the
therapeutic use of amniotic-derived cells, accurate long term
preclinical/clinical studies to evaluate AEC safety and stability in
host tissues are still required. In this context, one future target of
our group will be to compare the allogeneic stability and
regenerative properties of undifferentiated vs. differentiated AEC
when injected into an experimental induced tendon defect [57,58]
performed on a medium sized mammal, the sheep, selected for its
high translational value. Before the allotransplantation of the
differentiated AEC into immunocompetent animals, their immu-
nogenicity has to be tested trying to adapt the methods previously
described in other animal models [52,54–56].
Albeit, the study of the tenogenic regenerative properties of
AEC is of high value, this is not the aim of the present work that it
has been addressed to identify a low cost and efficient in vitro
cultural protocol able to stimulate tenogenic differentiation that
here it has been applied to ovine AEC.
The major limitation to translate this procedure in medicine
may be represented by the low availability of tendon/tenocytes
and, in particular, tendon/tenocytes of fetal origin, the co-culture
performed with sheep tenocyte/tendons may represent a cellular
culture system on which either identify the molecules involved into
the process of tenogenic in vitro differentiation or to produce high
amounts of conditioned media to use for human AEC/MSCs
differentiation.
Materials and Methods
Ethics statement
All cells and tissues were collected from slaughtered animals,
and this did not require an ethic statement.
AEC and tendon explants/tenocytes isolation and culture
In the present research, the co-culture system was used in order
to compare the inductive tenogenic potential of adult and fetal
tendon explants, or adult and fetal primary tenocytes on freshly
isolated ovine AEC. To this aim, adult calcaneal tendons and fetal
tissues (amniotic membrane and calcaneal tendons) were obtained
by slaughtered sheep. Adult tendons were collected by adult
female sheep, 2–3 years old, of Appenninica breed. The amniotic
membranes and fetal tendons were isolated from fetuses of 25–
35 cm of length, at approximately 2–3 months of pregnancy.
Once opened the uterus wall, the AEC were collected from
pieces of approximately 3–5 cm of the amniotic membranes that
were mechanically peeled off. Membrane pieces were washed in
Phosphate Buffered Saline (PBS; Sigma Chemical Co. St. Louis,
MO), and incubated in 0.25% Trypsin/EDTA 200 mg /L at
37.5uC for 20 minutes under gentle agitation. Then, cell
suspension was collected, filtered through a 40 mm cell filter and
poured into a 50 ml falcon tube containing FCS at a final
concentration of 10% to inactivate trypsin. Each falcon tube was
centrifuged, and the pelleted vital cells were counted after trypan-
blue staining by using a haemocytometer chamber. Isolated cells
were, then, used for flow cytometry analysis and for co-cultural
experiments.
– Calcaneal tendon explants were isolated from the forefeet and
deprived of the peritendineum under sterile conditions. Small
pieces of fresh tendon isolated from the middle portion of the
structures (about 1 mm
3 in size) were further mechanically
disaggregated under a stereomicroscope with the aid of fine
watchmaker forceps in order to maximize the interface
between tissue and medium. Tendon explants were immedi-
ately placed on the membranes of trans-wells (membrane
porosity 0.4 mm) of a 12 well chamber (Costar, NY, USA).
– Primary adult and fetal tenocytes were isolated after in vitro
incubation of calcaneal tendon explants. The culture were
performed in petri dishes of 25 mm containing 2 ml of a-MEM
supplemented with 10% FCS and 1 mL/100 mL L-glutamine
and antibiotics/antimycotic solution (penicillin G sodium
100 U/ml, streptomycin 100 mg/ml, amphotericin B
0.25 mg/ml; Gibco, Invitrogen, Carlsbad, CA, USA) at 38uC
in 5% CO2 and air.
Tenocytes were, then, isolated by using 0.25% Trypsin/EDTA
solution when the cells migrated out of tendon pieces and reached
60–80% of confluence (,4 days for fetal tendon explants and ,9
days for adult tendons). Collected tenocytes were immediately used
for the co-culture systems in order to avoid their rapid phenotype
drift with further in vitro passages [59].
Co-culture systems
The co-culture system was performed as described by Luo et al.
[18], with minor modifications. In detail, transwell chambers (pore
size 0,4 mm; Costar, NY, USA) containing primary tenocytes
(1610
4 cells/trans-well) or tendon explants (two-three explants of
1m m
3 in size/trans-well) were inserted into the wells plates. The
AEC were plated onto the well plates at 1610
4 cells/well. Each
trial was performed by simultaneously comparing the four
different conditions of co-culture (fetal and adult tendon explants
or primary tenocytes) each carried out at least in triplicate. The
incubation was performed in a-MEM supplemented with 10%
FCS in 5% CO2 and air at 38uC for 28 days. Half of the medium
was changed every 3 days during the first week of culture, and
then, every 1–2 days. The AEC in vitro differentiation was
monitored as described below.
AEC characterization
Freshly isolated AEC were immediately screened by flow
cytometry for the surface molecules CD14, CD29, CD31, CD45
CD49, CD58, CD117 and CD166 and for intracellular stem cell
markers (TERT, OCT4, SOX2, NANOG), as detailed below.
The primary antibodies used for the analysis were purchased as
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FITC marked by using Zenon Antibody Labelling Kit (Gibco,
Invitrogen, Carlsbad, CA, USA), following the manufacturer’s
instructions. Staining for flow cytometry were performed on
5610
5 cells/sample by incubating them with 100 mlo f2 0m M
ethylenediaminetetraacetic acid (EDTA) at 37uC for 10 minutes.
Cells were, then, washed in 3 ml of washing buffer (PBS, 0.1%
sodium azide and 0.5% Bovine Serum Albumine, BSA), and
centrifuged (4uC, 4006g, 8 minutes). For surface antigens staining,
cell samples were suspended in 100 ml washing buffer containing
the appropriate amount of surface antibody; samples were
incubated for 30 minutes at 4uC in the dark. Tubes were washed
(3 ml of washing buffer), centrifuged (4uC, 4006g, 8 minutes) and
cells were suspended with 1 ml 0.5% paraformaldehyde, incubat-
ed for 5 minutes at room temperature (RT), washed, centrifuged
(4uC, 4006g, 8 minutes) and stored at 4uC in the dark until the
acquisition. For intracellular antigens staining, cells were suspend-
ed in 1 ml of FACS Lysing solution (BD), vortexed and incubated
at RT in the dark for 10 minutes. Samples were, then, centrifuged
(4uC, 4006g, 8 minutes); 1 ml of Perm 2 (BD) was added to each
tube, and cells were incubated at RT in the dark for 10 minutes.
Samples were washed (3 ml of washing buffer) and centrifuged
(4uC, 4006g, 8 minutes). Cells were suspended in 100 mlo f
washing buffer containing the appropriate amount of intracellular
antibody and incubated for 30 minutes at 4uC in the dark. Tubes
were centrifuged (4uC, 4006g, 8 minutes), and cells suspended
with 1 ml 0.5% paraformaldehyde, incubated for 5 minutes at
RT, washed, centrifuged (4uC, 4006g, 8 minutes), and stored at
4uC in the dark until the acquisition. Finally, cells were analysed
on a FACSCalibur flow cytometer (BD), using CellQuest
TM
software (BD). Flow Cytometer Measurement was carried out by
using as quality control Rainbow Calibration Particles (6 peaks)
and CaliBRITE beads (both from BD Biosciences). Debris were
excluded from the analysis by gating on morphological parameters
(lymphocyte gate); 20.000 non-debris events in the morphological
gate were recorded for each sample. All antibodies were titrated
under assay conditions and optimal photomultiplier (PMT) gains
were established for each channel [60]. Data were analysed using
FlowJo
TM software (TreeStar, Ashland, OR). Mean Fluorescence
Intensity Ratio (MFI Ratio) was calculated dividing the MFI of
positive events by the MFI of negative events [61].
Finally, the plasticity and differentiation potential of ovine AEC
was tested in vitro by adopting validated methods to differentiate
amniotic derived cells in endoderm (liver) [62], mesoderm (bone)
[63], and ectoderm (neural cells) [64] cell lineages. In detail, for
hepatic differentiation, freshly isolated AEC cells were allowed to
proliferate for 2 days on well plates coated with Matrigel (BD
Bioscience) in a-MEM supplemented with 10% FCS and 10 ng/
ml epidermal growth factor (EGF; Sigma Chemical Co. St. Louis,
MO). On day 2, the medium was substituted with Iscove’s
modified Dulbecco’s medium (Lonza, Walkersville, MD) enriched
with 10% FCS, 10 ng/ml EGF and 10 ng/ml of fibroblast growth
factor (FGF 2; R&D Systems Inc., Minneapolis) for 48 hours, and
then, supplemented with 20 ng/ml of hepatic growth factor (HGF;
Gibco, Invitrogen, Carlsbad, CA, USA), 10
26 M dexamethasone
and 1% insulin/transferrin/selenium (Sigma Chemical Co. St.
Louis, MO), and the incubation was maintained for further 5 days.
Thereafter, the treatment was continued for an additional week,
with one exception: FGF 2 was replaced with 20 ng/ml
Oncostatin-M (Peprotec, Rocky Hill, NJ). Hepatic differentiation
was evaluated by the immunocytochemical expression of albumin
(Table 3). In order to evaluate the species-specificity of the used
antibody, primary mouse and ovine hepatocytes were used as
positive controls. Osteogenic differentiation was induced in a
standard osteogenic medium (a-MEM supplemented with 50 mM
ascorbic acid, 10 mM b-glicerol phosphate, 0.2 mM dexameth-
asone and 10% FCS) for 15 days, and assessed by the
extracellular matrix mineralization with Alizarin Red staining.
Neural differentiation was induced in standard medium supple-
mented with 5610
25 M all-trans retinoic acid (Sigma Chemical
Co. St. Louis, MO) and 10 ng/ml FGF (R&D Systems Inc,
Minneapolis, MN), for 10 days before assessing the immunocy-
tochemical expression of nestin (Table 3). In order to evaluate the
specie-specificity of the used antibody, human Glioma U87 cell
line and cryo-sectioned ovine myo-tendinous junctions were used
as positive controls.
Morphological and functional AEC evaluation after co-
culture
AEC morphology during the in vitro co-culture was followed
every 7 days under an inverted microscope. At each interval
points, AEC co-cultures were stopped and used for the following
analyses.
In detail, the proliferative activity was analyzed until AEC
reached the monolayer by calculating their doubling time. When
the AEC started to generate in culture three dimensional
structures, the mitotic activity of the cells was deduced by the
proliferation index. This parameter was recorded by using the
molecular marker Ki-67, a nuclear and nucleolar protein strictly
associated with cell proliferation [65,66]. The proliferation index
was calculated by counting the number of Ki-67 positive cells/
total cells counterstained with DAPI. To this aim, for each
experimental group three replicates were considered obtained
from three different experiments. Two trained observers blinded
to the experiment counted at least 200 cells for each replicate.
Table 2. Details of primary antibodies used in flow cytometry
analysis.
Antigen
Conjugated-
fluorescent
probe Company details
Hemopoietic markers
CD14 FITC LifeSpan Bioscences Seattle, WA, USA
CD58 FITC LifeSpan Bioscences Seattle, WA, USA
CD31 FITC AbD Serotec Oxford, UK
CD45 FITC AbD Serotec Oxford, UK
Adhesion molecules
CD29 VMRD Pullman, WA, USA
CD49f Beckman Coulter Fullerton, CA, USA);
CD166 FITC Ancell MN, USA
MHC antigens
Class I Novus Biologicals Cambridge UK
Class II HLA-DR Abcam Cambridge UK
Stemness markers
CD117 Abcam Cambridge, UK
SOX2 Abcam Cambridge, UK
OCT4 PE Becton Dickinson BD, San Jose, CA
TERT Calbiochem Gibbstown, NJ
NANOG Chemicon Int. Billerica, MA
doi:10.1371/journal.pone.0030974.t002
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to Stalling [28] in order to monitor the epithelial-mesenchymal
transition. Before AEC aggregation occurred, co-cultured cells
were trypsinized and put over a Nunc cover slide chamber (4 cm
2)
containing in the middle a 1-mm wide silicone rubber strip. A total
of 2610
6 cell/ml cell was seeded. After 1 hour, when the cells
started to adhere, each well was covered with a-MEM containing
mitomycin to stop cell proliferation. Twenty four hours later,
silicone strips were carefully removed. Wells were rinsed gently in
order to remove cellular debris, and cell recording started
(Axiovert 200 & Axiovision; Carl Zeiss, Thornwood, NY). The
analyses were performed by capturing the field images after
16 hours (Axiovision and KS300; Carl Zeiss) to track migration.
The width of the cell-free zone was photographed and compared
at time 0 and after 16 hours. The migration assays were
performed on six different replicates/co-cultural groups.
The in vitro stability of the co-cultured AEC was evaluated by
comparing telomere sizes, the karyotype, and the expression of
MHC antigen Class I and II before and at the end of the
incubation interval.
Telomere size detection was performed by using the Quanti-
tative Fluorescence In Situ Hybridisation (Q-FISH) [67]. In
detail, confluent cultured and co-cultured AEC were transferred
in dishes and incubated a 37uC for 24–48 hours in Chang
Medium (Irvine Scientific). Cells were treated with a pre-warmed
(37uC) hypotonic solution (0.06 M KCl) before fixing them in 3:1
methanol: acetic acid (Carnoy’s fixative). The air dried cover slips
were then applied to the slides with a drop of EN-Aquivitrex Erba
(Carlo Erba, Italy). Slides were then placed in 26 SSC at 45uC
for 5 minutes, digested with pre-warmed (37uC) pepsin solution
(1 mg/ml; Sigma) at RT for 7 minutes, thoroughly rinsed with
PBS, and fixed in 4% paraformaldehyde/PBS for 3 minutes at
RT before dehydration in ethanol series (70%, 95%, 100% at
2 minutes each). Interphase nuclei were denatured with 70%
formamide (Carlo Erba) in 26SSC, pH 7.0 at 75.5uC for 5 min.,
followed immediately by dehydration in ice-cold ethanol (70%,
95%, 100% at 2 minutes each). A denatured all-human telomeric
DNA probe, since eukaryotic chromosomes, as well as the sheep
[68], contain conserved non-coding sequences of DNA repeats
(TTAGGG)n, was added to each slide (Qbiogene – Resnova).
The incubation with telomeric DNA probe was performed
overnight at 37uC in a humidified chamber, and post-hybridized
with 50% formamide (Carlo Erba) in 26 SSC at 37uCf o r
10 minutes. The hybridized signals were then detected by using a
commercial kit (Cy3 avidin detection kit; Oncor Inc.) according
to the manufacturer’s instructions. DAPI/Antifade mounting
medium (Vectashield, Vector Laboraties, Inc. Burlingame, CA)
was used for chromatin counterstaining. All slides were analyzed
using an Axioskop 2 Plus incident-light fluorescence microscope
(Zeiss) equipped with a PL-Neofluorar 6100 oil immersion
objective (NA 1.30) and a 610 ocular to provide images with a
spatial resolution of 0.25 mm, a HBO 100 W mercury lamp, a
Cy3 filter (excitation: BP546/12; emission: BP575–640; no. 20,
Zeiss), and a DAPI filter (excitation: BP 365/12; emission: LP
397; no. 01, Zeiss). The microscope was equipped with a cooled
color CCD camera (Axiovision Cam, Zeiss) with a resolution of
130061030 pixels, configured for fluorescence microscopy, and
interfaced to an image acquisition dedicated software (Axiovision,
Zeiss). Digital image analysis of telomere length was performed
according to Russo et al. [69]. Since in interphase nuclei
telomeres are distributed throughout the nucleus, the focus of the
microscope was adjusted so that most telomeres were in focus.
For quantitative purposes digital images were captured from at
least 100 interphase nuclei in each specimen immediately after
hybridization. At the beginning of an imaging session, optimum
exposure times were determined and held constant thereafter. In
all cases, it was confirmed that the telomeric signals were within
the linear response range of the CCD camera using, according to
Meeker et al. [70], standard fluorescent microbeads (InSpeck
microspheres; Molecular Probes, Inc.). In brief, quantification of
the digitized fluorescent telomere signals was accomplished by
using a semi-automated algorithm written with the image analysis
software package KS300 (Zeiss), as described in Russo et al. [69].
Parameters to be measured included mean densitometric value,
area and feret maximum, which corresponds to the value of the
major diagonal connecting the two farthest points at the
periphery of the object. Results were then recorded for statistical
evaluation.
Karyotype evaluation was performed in AEC before and after
the different cultural conditions. Cells were harvested from flask
after trypsin digestion, transferred in amniodish and then
incubated at 37uC for 24–48 hours in Chang medium (Irvine
scientific). Metaphase cells were arrested with 0.1 mg/ml colchi-
cine for 2 hours at 37uC. Then, treated with hypotonic solution
(0.06 M KCl) and incubated for 20 minutes at 37uC. Cells were
fixed in methanol/glacial acetic acid (3:1) for 10 minutes.
Metaphase chromosomes were subjected to GTG-banding and
Giemsa staining. A median of 30–40 metaphases were examined
Table 3. Details of primary and secondary antibodies used for immunohistochemistry.
Primary Abs (Company details) Primary Ab dilutions Secondary Abs (Company details) Secondary Ab dilutions
Ki-67 (Dako Cytomation, Denmark) 1:50 Anti-Mouse Alexa Fluor 488 (Invitrogen Ltd, Paisley, UK) 1:100
COL1 (Chemicon Int. Billrerica, MA) 1:100 Anti-Mouse FITC (Sigma-Aldrich, Missouri, USA) 1:500
Cytokeratin 8 (Abcam, Cambridge, UK) 1:200 Anti-Mouse Cy3 (Sigma-Aldrich, Missouri, USA) 1:500
a-SMA (Abcam, Cambridge, UK) 1:500 Anti-Mouse FITC (Sigma-Aldrich, Missouri, USA) 1:100
Albumin (V-14) (Santa Cruz Biotechnology,
California, USA)
1:100 Anti-Goat Alexa Fluor 488 (Invitrogen Ltd, Paisley, UK) 1:250
Nestin, clone 10C2 (Millipore, Billerica, MA) 1:250 Anti-Mouse Cy3 (Sigma-Aldrich, Missouri, USA 1:500
Cx43 (Chemicon Int. Billrerica, MA) 1:200 Anti-Mouse Cy3 (Sigma-Aldrich, Missouri, USA) 1:500
Cx32 (Chemicon Int. Billrerica, MA) 1:200 Anti-Mouse Alexa Fluor 488 (Invitrogen Ltd, Paisley, UK) 1:750
Osteocalcin (Abcam, Cambridge, UK) 1:50 Anti-Mouse Alexa Fluor 488 (Invitrogen Ltd, Paisley, UK) 1:400
Primary and secondary antibodies (Abs) are diluted in PBS supplemented with 1% BSA.
doi:10.1371/journal.pone.0030974.t003
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Nikon Eclipse 80i microscope and analyzed by Genikon software
(Nikon). A normal ovine karyotype consists in 27 pairs (2n=54) of
chromosomes. A chromosomal aberration was defined as clonal
when at least two metaphases showed the same abnormality.
Finally the major histocompatibility antigens of class I and II
(HLA-DR) were evaluated before and after co-culture by using
flow cytometry as discussed above by using the primary antibodies
described in Table 2.
Immunohistochemistry
In addition, the AEC incubated under different co-cultural
systems were, then, tested in order to monitor with immunohis-
tochemistry:
– Cytokeratin 8 and a-SMA to test the transition from epithelial
to mesenchymal lineage,
– OCN, a generic mesenchymal derived tissue marker molecule,
– COL1, an abundant tendon matrix component,
– Cx 32 and Cx 43, two tendon gap junction proteins.
In detail, immunohistochemistry was carried out on cultured
and co-cultured AEC for 7, 14 or 28 days. For the single
immunostainings, cells contained in each well were fixed for
10 minutes with 4% paraformaldehyde/PBS. After washing with
PBS, cells were permeabilized with 0.1% Triton X-100/PBS for
10 minutes at RT. The AEC were blocked by incubating at RT in
PBS/1% BSA for 1 hour. Cells were, then, incubated with the
primary antibody (Ab) overnight at RT, and then, exposed to the
secondary Ab for 40 minutes at RT. Experiments with the
omission of primary Abs were used as negative controls. Cell
nuclei were identified with DAPI counterstaining.
Double immunocytochemistry for Cx32 and Cx43: after
washing with PBS, cells were blocked at RT in PBS/1% BSA
for 1 hour. Samples were then incubated with a mouse
monoclonal anti-Cx32 Ab overnight at 4uC. Next, the cells were
washed in PBS, and incubated with an anti-mouse Alexa Fluor488
for 60 minutes, and washed again in PBS. After this first step, a
post-fixation with 4% paraformaldehyde/PBS for 10 minutes at
4uC was performed. Then, after thoroughly washes, the samples
were incubated with a mouse monoclonal anti-Cx43 Ab overnight
at RT and revealed with a Anti-Mouse Cy3. All details on the
primary and secondary Abs are shown in Table 2.
Total RNA isolation and RT-PCR
RT-PCR analyses were performed on ovine native tendons
(adult and fetal), and on cultured and co-cultured AEC after 28
days of incubation in order to compare the expression of specific
genes, summarized in Table 4.
In particular:
– SCXB, a bHLH transcription factor gene a crucial marker for
the tendon cell fate [38,71] and embryogenetic tendon
differentiation marker [71–73],
– COL1 and 3, the main components of extracellular matrix,
– TNMD, tendon transmembrane glycoproteins [74],
– THBS4, extracellular matrix protein,
– OCN, a generic mesenchymal derived tissue related protein.
In detail, total mRNA was extracted by using TRI Reagent
(Sigma) according to the manufacturer’s instructions. Integrity and
size distribution were evaluated by 1% agarose gel electrophoresis
and ethidium bromide staining. Digestion of genomic DNA was
carried out by DNaseI digestion (Sigma) for 15 minutes at RT.
1 mg of total RNA of each sample was used for reverse
transcription reaction with Oligo dT primer and BioScriptTM
Kit (Bioline). 26Ready mix
TM Taq PCR Reaction mix (Sigma)
was used for PCR reaction using 3 ml of cDNA and 0.5 mMo f
each primer, in a final volume of 25 ml. The primer sequences,
Genebank number of reference mRNA sequence, product length
and cycles are shown in Table 4. The reaction mixtures were
incubated for 5 minutes at 95uC, followed by 95uCf o r
30 seconds, 55uC for 30 seconds, 72uC for 45 seconds and
72uC for 7 minutes. For each gene, a reaction mixture with water
instead of cDNA template was run at the same time as a PCR
negative control. RT-PCR was normalized by the transcriptional
levels of GAPDH. The PCR products were separated on 2%
agarose gel stained with ethidium bromide, visualized on a Gel
Doc 2000 (Biorad) and analyzed with Quantity One 1-D Analysis
software (Biorad). Each PCR reaction was carried out in
triplicate.
Statistical analysis
Data reported in this paper are the mean (6SD) of at least 3
independent experiments, each performed in triplicate. The data
were checked for parametric distribution by Shapiro-Wilks W test,
before comparing them with ANOVA test followed, if necessary,
by post-hoc Tukey test (StatistiKL Version b). The differences were
considered significant and highly significant for p,0.05 and
,0.01, respectively.
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Table 4. Primer sequences used in RT-PCR analyses.
Gene Accession No. Primer sequences
Product
size(bp)
PCR
Cycles
COL1 AF129287.1 F: CGTGATCTGCGACGAACTTAA 212 40
Ovine R: GTCCAGGAAGTCCAGGTTGT
COL3 AY091605.1 F: AAGGGCAGGGAACAACTTGAT 355 40
Ovine R: GTGGGCAAACTGCACAACATT
TNMD NM_001099948.1 F: TGGTGAAGACCTTCACTTTCC 352 40
Bos Taurus R: TTAAACCCTCCCCAGCATGC
THBS4 NM_001034728.1 F: CCGCAGGTCTTTGACCTTCT 231 40
Bos Taurus R: CAGGTAACGGAGGATGGCTTT
SCXB XM_866422.2 F: AACAGCGTGAACACGGCTTTC 299 45
Bos Taurus R: TTTCTCTGGTTGCTGAGGCAG
OCN DQ418490.1 F: AGACACCATGAGAACCCCCAT 234 40
Ovine R: TTGAGCTCACACACCTCCCT
GAPDH AF030943.1 F: CCTGCACCACCAACTGCTTG 224 40
Ovine R: TTGAGCTCAGGGATGACCTTG
doi:10.1371/journal.pone.0030974.t004
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